Suggestions
Mike Nolan
Chief Executive Officer at Freenome
Professional Background
Mike Nolan is a distinguished leader in the medical and diagnostics industry, serving as the Chief Executive Officer of Freenome. With almost 30 years of experience, he has garnered an impressive track record of delivering transformative diagnostic technologies designed to enhance clinical outcomes. Under his guidance, Freenome has advanced in the field of multiomics, providing innovative solutions that propel research and medicine. Mike previously excelled as the Chief Business Officer at Freenome, where he expertly managed corporate development, product management, clinical developments, operations, and marketing teams. His extensive leadership skills have been pivotal in forging successful partnerships with biopharma companies, academic medical centers, and health systems.
Prior to his tenure at Freenome, Mike played an integral role at Foundation Medicine as the Senior Vice President of Commercial Operations. There, he led a multidisciplinary team to significantly expand the application of next-generation sequencing technologies in the realm of cancer diagnostics, showcasing his ability to drive technological adoption in critical sectors of healthcare.
Mike’s career also includes influential leadership roles at numerous renowned companies including Thermo Fisher Scientific, Luminex Corporation, Roche Molecular Systems, and Abbott Diagnostics. His expertise spans global general management, commercial leadership, and biosciences, illustrating his comprehensive understanding of the diagnostic landscape.
Education and Achievements
Mike's educational background is rooted in science and management. He holds a Bachelor of Science (B.S.) degree in Biological Sciences and Secondary Education, alongside a Master of Business Administration (MBA) from the University of Wyoming. This strong educational foundation has equipped him with both the scientific insight and business acumen necessary for leadership roles in the highly competitive medical diagnostics industry.
Throughout his extensive career, Mike has consistently demonstrated his ability to lead teams and drive success in various capacities. His leadership at Freenome and Foundation Medicine highlights his commitment to harnessing cutting-edge technology to improve patient care through precise diagnostics.
Notable Achievements
- Transformational Leadership: As CEO of Freenome, Mike has guided the development of a multiomics platform that is significantly enhancing cancer research and diagnostics.
- Expansion of Next-Generation Sequencing: Under his leadership at Foundation Medicine, he was instrumental in broadening the application of next-generation sequencing technologies, thereby revolutionizing cancer diagnostic methods.
- Strategic Growth: Mike has successfully navigated complex corporate strategies, overseeing corporate and business development initiatives that have contributed to the growth of Freenome and its partners.
- Partnerships and Collaborations: He adeptly established collaborations with major health systems, biopharma companies, and academic institutions, fostering a collaborative environment for advancing clinical research.
- Expert Team Leadership: His roles at various companies have showcased his capacity to lead cross-functional teams to achieve critical objectives, driving operational effectiveness across multiple facets of the business.